Desktop Stock Ticker | Stock Analysis: Cardinal Health Inc. (CAH)

Stock Analysis: Cardinal Health Inc. (CAH)

Linked here is a detailed quantitative analysis of Cardinal Health Inc. (CAH). Below are some highlights from the above linked analysis:

Company Description: Cardinal Health Inc. is one of the leading wholesale distributors of pharmaceuticals, medical/surgical supplies and related products to a broad range of health care customers.

Honest Value: I consider four calculations of honest value, see page 2 of the linked PDF for a detailed description:

  1. Avg. High Yield Price
  2. 20-Year DCF Price
  3. Avg. P/E Price
  4. Graham Number

CAH is trading at a discount to 1.) and 3.) above. The stock tickers is trading at a affront premium to its calculated honest value of $32.22. CAH did not earn any Stars in this section.

Dividend Questioning Data: In this section there are three possible Stars and three key metrics, see page 2 of the linked PDF for a detailed description:

  1. Free Cash Flow Payout
  2. Debt To Total Capital
  3. Key Metrics
  4. Dividend Growth Rate
  5. Years of Div. Growth
  6. Rolling 4-yr Div. > 15%

CAH earned three Stars in this section for 1.), 2.) and 3.) above. A Star was earned since the Free Cash Flow payout ratio was less than 60% and there were no unenthusiastic Free Cash Flows over the last 10 years. The stock tickers earned a Star as a result of its most recent Debt to Total Capital being less than 45%. CAH earned a Star for having an acceptable score in at smallest amount two of the four Key Metrics measured. Rolling 4-yr Div. > 15% means that dividends grew on average in excess of 15% for each consecutive 4 year period over the last 10 years (2000-2003, 2001-2004, 2002-2005, etc.) I consider this a key metric since dividends will double every 5 years if they grow by 15%. The company has paid a cash dividend to shareholders every year since 1983 and has increased its dividend payments for 14 consecutive years.

Dividend Income vs. MMA: Why would you assume the equity risk and invest in a dividend stock tickers if you could earn a better return in a much less risky money market account (MMA)? This section compares the earning ability of this stock tickers with a high yield MMA. Two items are considered in this section, see page 2 of the linked PDF for a detailed description:

  1. NPV MMA Diff.
  2. Years to > MMA

CAH earned a Star in this section for its NPV MMA Diff. of the $6,254. This amount is in excess of the $2,100 target I look for in a stock tickers that has increased dividends as long as CAH has. If CAH grows its dividend at 17.6% per year, it will take 5 years to equal a MMA yielding an estimated 20-year average rate of 3.98%.

Other: CAH is a member of the S&P 500 and a member of the Broad Dividend Achievers™ Index.

Conclusion: CAH did not earn any Stars in the Honest Value section, earned three Stars in the Dividend Questioning Data section and earned one Star in the Dividend Income vs. MMA section for a total of four Stars. This quantitatively ranks CAH as a 4 Star-Buy.

Using my D4L-PreScreen.xls develop, I determined the share price would need to increase to $48.44 before CAH’s NPV MMA Differential decreased to the $2,100 minimum that I look for in a stock tickers with 14 years of consecutive dividend increases. At that price the stock tickers would yield 1.44%.

Resetting the D4L-PreScreen.xls develop and solving for the dividend growth rate needed to generate the target $2,100 NPV MMA Differential, the calculated rate is 14.1%. This dividend growth rate is less than the 17.6% used in this analysis, thus providing only a margin of safety. CAH has a <a href="http://dividendsvalue.com/426/refining-risk-measurement-of-dividend-stock tickerss/”>risk rating of 1.50 which classifies it as a low risk stock tickers.

CAH’s customer relationships and established distribution infrastructure provide notable scale advantages. Its diversified line of products and air force provide excellent growth prospects for its contract drugmaking and its drug dispensing systems. The company is making steady progress in its performance initiatives by reducing the number of its generic drug suppliers, expanding its retail business and focusing on cost control. The stock tickers is trading near my honest value price of $32.22. Though, I am hesitate to buy with its yield at 2.19%. For additional information, including the stock tickers‘s dividend history, please refer to its data page.

Disclaimer: Material presented here is for informational purposes only. The above quantitative stock tickers analysis, including the Star rating, is involuntarily calculated and is based on historical information. The analysis assumes the stock tickers will perform in the future as it has in the past. This is generally never right. Before buying or selling any stock tickers you should do your own research and get to your own conclusion. See my Disclaimer for more information.

Full Disclosure: At the time of this writing, I held no position in CAH (0.0% of my Income Selection). See a list of all my income holdings <a href="http://dividendsvalue.com/holdings/dividend-stock tickers-and-etfcef-holdings/”>here.

Recent stock tickers Analyses:

This article was written by Dividends4Life. If you loved this article, please vote for it by clicking the Buzz Up! button below. [RSS] [Email] [Twitter]

Related posts:

Stock Analysis: Emerson Electric Co. (EMR)Linked here is a detailed quantitative analysis of Emerson Electric Co. (EMR). Below are some...
Related posts:

Stock Analysis: SYSCO Corporation (SYY)Linked here is a detailed quantitative analysis of SYSCO Corporation (SYY). Below are some highlights...
Related posts:

Stock Analysis: Nucor Corporation (NUE)Linked here is a detailed quantitative analysis of Nucor Corporation (NUE). Below are some highlights...
Related posts:

Stock Analysis: Cincinnati Financial Corp. (CINF)Linked here is a detailed quantitative analysis of Cincinnati Financial Corp. (CINF). Below are some...
Related posts:

Stock Analysis: Raven Industries Inc. (RAVN)Linked here is a detailed quantitative analysis of Raven Industries Inc. (RAVN). Below are some...
Related posts:

Stock Analysis: AT&T Inc. (T)Linked here is a detailed quantitative analysis of AT&T Inc. (T). Below are some highlights...
Related posts:

Stock Analysis: Harleysville Group Inc. (HGIC)Linked here is a detailed quantitative analysis of Harleysville Group Inc. (HGIC). Below are some...
Related posts:

Stock Analysis: Becton, Dickinson and Co. (BDX)Linked here is a detailed quantitative analysis of Becton, Dickinson and Co. (BDX). Below are...
Related posts:

Stock Analysis: United Technologies Corp. (UTX)Linked here is a detailed quantitative analysis of United Technologies Corp. (UTX). Below are some...
Related posts:

McCormick and Company – Stock Analysis for Dividend Growth PortfolioMcCormick & Company Inc (MKC) is the world’s largest spice company, with operations in the...

Related posts brought to you by Yet Another Related Posts Plugin.

-->

Filed Under Desktop Stock Ticker, stock market news | Leave a Comment

Tagged With

Comments

Leave a Reply

You must be logged in to post a comment.